Posted on 03/29/2021 9:15:47 PM PDT by SeekAndFind
Boris Johnson has announced a new partnership with pharmaceutical giant GlaxoSmithKline, to provide 60 million doses of the new Novavax vaccination in the fight against Covid-19.
BORIS JOHNSON: And at the same time as we push forward with our program to offer a vaccination to all adults by the end of July, we're building up our own long term UK manufacturing capabilities. I've already told you that Novavax, a potentially significant new weapon in our armory against COVID, is going to be made at Fujifilm in the northeast.
And I can today announce that the vaccine taskforce has reached an agreement with GlaxoSmithKline to finish and bottle this precious fluid also in the northeast, giving us between 50 and 60 million doses of UK made vaccine subject to the right approvals from the MHRA.
(Excerpt) Read more at news.yahoo.com ...
– How does the Novavax vaccine work?
The Novavax vaccine works like other vaccines by teaching the immune system to make antibodies to the coronavirus spike protein.
Researchers inserted a modified gene into a virus, called a baculovirus, and allowed it to infect insect cells.
Spike proteins from these cells were then assembled into nanoparticles which, while they look like coronavirus, cannot replicate or cause Covid-19.
These nanoparticles are then injected into the body via the vaccine where the immune system mounts an antibody response.
If the body encounters coronavirus in the future, the body is primed to fend it off.
The vaccine is given as two doses.
– Are there advantages of the Novavax vaccine?
Yes. While the jabs from Pfizer/BioNTech and Moderna need to be kept at ultra-low temperatures, the Novavax jab is stable for up to three months in a normal fridge.
– How effective is the Novavax vaccine?
According to results of a phase three trial in the UK, announced in March, the jab offers 100% protection against severe disease, including all hospital admission and death.
It is 86% effective against the Kent variant, the company behind it said, and it is also 96% effective in preventing cases caused by the original strain of the coronavirus.
The study in the UK enrolled more than 15,000 participants aged between 18 and 84, including 27% over the age of 65.
In participants 65 years of age and older, 10 cases of Covid-19 were observed, with 90% of those cases occurring in the placebo group.
– Where is the Novavax vaccine made?
The protein antigen component of the vaccine is produced in the North East of England by Novavax manufacturing partner, Fujifilm Diosynth Biotechnologies, at its site in Billingham, Stockton-on-Tees
GSK announced on Monday that it will provide “fill and finish” manufacturing capacity – preparing vials of the final vaccine and packaging them for distribution and use – at its Barnard Castle facility, also in the North East, beginning as early as May.
It said the “rapid technology transfer” between the two companies will begin immediately.
– Has the Novavax vaccine been approved?
Not yet. A rolling review is under way by the (Medicines and Healthcare products Regulatory Agency) MHRA to assess the vaccine.
MORE HERE:
https://www.fool.com/investing/2021/03/28/is-novavax-a-buy/?source=iedfolrf0000001
[EXCERPT]
Unfortunately, Novavax is having trouble turning a profit after those initial lucrative preorders. For starters, it’s donating up to 1.1 billion doses of its experimental vaccine to developing nations.
Secondly, the company is now delaying a 200 million-dose supply agreement with the EU due to a U.S. export ban on the vaccine’s raw materials. Novavax has eight production facilities/contract manufacturing organizations around the world to assemble NVX-CoV2373. The largest of these is the Serum Institute of India, which promises to make over 1 billion doses of Novavax’s vaccine candidate each year.
Nevertheless, it doesn’t have the actual biologics to make coronavirus vaccines and must first import them from the U.S. Given the not surprising “America First” focus of the Biden administration regarding such vaccines, it’s likely that Novavax’s supply will be delayed until July. That brings up another problem. By now, most developed nations have secured vaccine supply agreements from competitors such as AstraZeneca, Pfizer, BioNTech, CureVac, Johnson & Johnson, and Moderna, ranging from 2 to 9 doses per capita.
In other words, the coronavirus vaccine market has mostly been maxed out by the governments that can pay. If there are any leftover doses after vaccinations are complete, they would be given to third-world countries free of charge or at no profit.
I’d consider that jab. Like Johnson and Johnson. But Pa just cut back distribution in our state from what they were going to send out.
Sold is soul, ee did.
1 Face-masks
2 hypodermic jabs
3 vaccine passports
Does anyone see a pattern here ?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.